secwatch.observer — SEC 8-K summary
======================================

Issuer:     KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)
CIK:        0000055529
Form:       8-K
Filed at:   2026-06-23T21:10:03+00:00
Accession:  0000055529-26-000017
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kewaunee Scientific reports FY2026 revenue up 17.3% to $282M; EPS down to $3.22 from $3.83
--------------------------------------------------------------------------------

- Full-year sales $281.999M (+17.3% YoY); net earnings $9.618M vs $11.405M prior year.
- Diluted EPS $3.22 compared to $3.83; EBITDA $22.425M vs $21.613M.
- Lab Products Group segment sales $214.886M (+19.8%), net earnings $14.156M vs $15.370M.
- Company cites challenging market conditions including tariff costs, partly offset by productivity gains.
- Nu Aire integration and balance sheet improvement noted as positives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/55529/000005552926000017/0000055529-26-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/55529/000005552926000017/kequ-20260623.htm
  HTML page:      https://secwatch.observer/filing/0000055529-26-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer